CRP and Miyoshi myopathy: There were no significant differences between the two groups of patients in age, sex, clonal bone marrow plasma cells, CPC, hemoglobin, albumin, creatinine, β2-MG, LDH, hs-CRP, extramedullary myeloma, MM type, high-risk CA, D-S, ISS, R-ISS, first line therapy regimens, ASCT, or response rates.